Achilles Therapeutics(us:ACHL)
0.0000
Updated on 2025-04-02
Open:0.0000
Close:0.0000
High:0.0000
Low:0.0000
Prev Close:0.0000
Volume:0.00
Turnover:0.00
Turnover Ratio:0.00%
Shares:42.59M
MarketCap:0.00
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 35 | 22188684 | 54.00% | 3 | 5 | 14 |
| 2024-03-31 | 33 | 23510490 | 57.22% | 13 | 5 | 9 |
| 2023-12-31 | 23 | 21782205 | 53.02% | 5 | 3 | 7 |
| 2023-09-30 | 20 | 19692070 | 48.28% | 3 | 3 | 6 |
| 2023-06-30 | 22 | 19788440 | 48.33% | 3 | 1 | 10 |
| 2023-03-31 | 25 | 20237776 | 49.43% | 2 | 5 | 9 |
| 2022-12-31 | 35 | 21665785 | 52.93% | 7 | 4 | 18 |
| 2022-09-30 | 30 | 27270258 | 66.61% | 5 | 9 | 8 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Syncona Portfolio Ltd | 11086909 | 26.98% | 0 | |
| 2024-03-31 | Fcpm Iii Services B.V. | 2390050 | 5.82% | 0 | |
| 2024-03-31 | Redmile Group, Llc | 1608089 | 3.91% | 0 | |
| 2024-03-31 | Vestal Point Capital, Lp | 1500000 | 3.65% | 1391917 | 1287.82% |
| 2024-03-31 | Ikarian Capital, Llc | 1443181 | 3.51% | 1443181 | |
| 2024-03-31 | Stempoint Capital Lp | 1385750 | 3.37% | 1385750 | |
| 2024-03-31 | Baker Bros. Advisors Lp | 1208775 | 2.94% | -894017 | -42.52% |
| 2024-03-31 | Renaissance Technologies Llc | 1005759 | 2.45% | 506764 | 101.56% |
| 2024-03-31 | Artal Group S.A. | 755375 | 1.84% | -1500000 | -66.51% |
| 2024-03-31 | Boothbay Fund Management, Llc | 420481 | 1.02% | 420481 |
About
Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. The company was founded by Karl Peggs, Sergio Quezada, Mark Lowdell and Charles Swanton in November 2020 and is headquartered in London, the United Kingdom.
Address:245 Hammersmith Road
Website:http://www.achillestx.com
Market Movers